Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

NCT: NCT06699810 · ACTIVE_NOT_RECRUITING

NCT IDNCT06699810
StatusACTIVE_NOT_RECRUITING
Start Date2025-01-23
Completion2026-06

Brief Summary

The goal of this study is to quantify day-to-day changes in blood glucose during treatment towards remission in ketosis-prone diabetes (KPDM) and describe them using a mathematical model of KPDM pathogenesis and remission.

Frequently Asked Questions

What is Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity?

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity is a clinical trial registered under NCT06699810. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06699810?

The current status of NCT06699810 (Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity) is: ACTIVE_NOT_RECRUITING.

When did Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity start?

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity started on 2025-01-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑